Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-09-06

FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)

View source ↗

Summary

The FDA approved Eisai's supplemental application for Aricept (donepezil hydrochloride).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aricept (Donepezil)

Snippet

SUPPL AP for ARICEPT (DONEPEZIL HYDROCHLORIDE)